Cargando…
MeCP2 Epigenetic Silencing of Oprm1 Gene in Primary Sensory Neurons Under Neuropathic Pain Conditions
Opioids are the last option for the pharmacological treatment of neuropathic pain, but their antinociceptive effects are limited. Decreased mu opioid receptor (MOR) expression in the peripheral nervous system may contribute to this. Here, we showed that nerve injury induced hypermethylation of the O...
Autores principales: | Sun, Na, Yu, Lina, Gao, Yibo, Ma, Longfei, Ren, Jinxuan, Liu, Ying, Gao, Dave Schwinn, Xie, Chen, Wu, Ying, Wang, Lieju, Hong, Juncong, Yan, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602696/ https://www.ncbi.nlm.nih.gov/pubmed/34803588 http://dx.doi.org/10.3389/fnins.2021.743207 |
Ejemplares similares
-
Bioinformatics Analysis Identifies p53 as a Candidate Prognostic Biomarker for Neuropathic Pain
por: Gao, Yibo, et al.
Publicado: (2018) -
ZNF382 controls mouse neuropathic pain via silencer-based epigenetic inhibition of Cxcl13 in DRG neurons
por: Ma, Longfei, et al.
Publicado: (2021) -
MeCP2: The Genetic Driver of Rett Syndrome Epigenetics
por: Good, Katrina V., et al.
Publicado: (2021) -
Epigenetic Dysfunction of Neurodegenerative Diseases, MeCP2 and More
por: Im, Heh-In
Publicado: (2022) -
MeCP2 and Chromatin Compartmentalization
por: Schmidt, Annika, et al.
Publicado: (2020)